Qodebook Right Code · Any Purpose

Introduction of anti-inflammatory into nose, via natural or artificial opening

Commodity a leaf — nothing below it, 8 links to KBLI

Level
Commodity
Parent
85811900
Below
0
Links · KBLI
8

Definition

UNSPSC 85811934

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of anti-inflammatory into nose, via natural or artificial opening.This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E0973Z

Same parent

Under 85811900 · 38
85811901 Introduction of destructive agent into eye, via natural or artificial opening Commodity 85811902 Introduction of other gas into eye, via natural or artificial opening Commodity 85811903 Introduction of analgesics, hypnotics, sedatives into eye, via natural or artificial opening Commodity 85811904 Introduction of pigment into eye, via natural or artificial opening Commodity 85811905 Introduction of other diagnostic substance into eye, via natural or artificial opening Commodity 85811906 Introduction of radioactive substance into eye, via natural or artificial opening Commodity 85811907 Introduction of other therapeutic substance into eye, via natural or artificial opening Commodity 85811908 Introduction of local anesthetic into eye, via natural or artificial opening Commodity 85811909 Introduction of anti-inflammatory into eye, via natural or artificial opening Commodity 85811910 Introduction of other anti-infective into eye, via natural or artificial opening Commodity 85811911 Introduction of oxazolidinones into eye, via natural or artificial opening Commodity 85811912 Introduction of monoclonal antibody into eye, via natural or artificial opening Commodity 85811913 Introduction of other antineoplastic into eye, via natural or artificial opening Commodity 85811914 Introduction of liquid brachytherapy radioisotope into eye, via natural or artificial opening Commodity 85811915 Introduction of destructive agent into ear, via natural or artificial opening Commodity 85811916 Introduction of analgesics, hypnotics, sedatives into ear, via natural or artificial opening Commodity 85811917 Introduction of other diagnostic substance into ear, via natural or artificial opening Commodity 85811918 Introduction of radioactive substance into ear, via natural or artificial opening Commodity 85811919 Introduction of other therapeutic substance into ear, via natural or artificial opening Commodity 85811920 Introduction of local anesthetic into ear, via natural or artificial opening Commodity 85811921 Introduction of anti-inflammatory into ear, via natural or artificial opening Commodity 85811922 Introduction of other anti-infective into ear, via natural or artificial opening Commodity 85811923 Introduction of oxazolidinones into ear, via natural or artificial opening Commodity 85811924 Introduction of monoclonal antibody into ear, via natural or artificial opening Commodity 85811925 Introduction of other antineoplastic into ear, via natural or artificial opening Commodity 85811926 Introduction of liquid brachytherapy radioisotope into ear, via natural or artificial opening Commodity 85811927 Introduction of destructive agent into nose, via natural or artificial opening Commodity 85811928 Introduction of analgesics, hypnotics, sedatives into nose, via natural or artificial opening Commodity 85811929 Introduction of other diagnostic substance into nose, via natural or artificial opening Commodity 85811930 Introduction of radioactive substance into nose, via natural or artificial opening Commodity 85811931 Introduction of other therapeutic substance into nose, via natural or artificial opening Commodity 85811932 Introduction of local anesthetic into nose, via natural or artificial opening Commodity 85811933 Introduction of serum, toxoid and vaccine into nose, via natural or artificial opening Commodity 85811934 Introduction of anti-inflammatory into nose, via natural or artificial opening You are here 85811935 Introduction of other anti-infective into nose, via natural or artificial opening Commodity 85811936 Introduction of oxazolidinones into nose, via natural or artificial opening Commodity 85811937 Introduction of monoclonal antibody into nose, via natural or artificial opening Commodity 85811938 Introduction of other antineoplastic into nose, via natural or artificial opening Commodity

Activities that produce or sell this

KBLI · 8

Inherited from family 85810000.

75002 Aktivitas Pengelolaan Sarana Kesehatan Hewan Sub-class 86101 Aktivitas Rumah Sakit Pemerintah Sub-class 86102 Aktivitas Puskesmas Sub-class 86103 Aktivitas Rumah Sakit Swasta Sub-class 86104 Aktivitas Klinik Pemerintah Sub-class 86105 Aktivitas Klinik Swasta Sub-class 86109 Aktivitas Rumah Sakit Lainnya Sub-class 86202 Aktivitas Praktik Dokter Spesialis Sub-class

Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.